These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5432717)

  • 21. [Study of 30 parkinsonian patients treated for 6 months with L-Dopa].
    Barbizet J; Duizabo P
    Therapie; 1972; 27(1):133-40. PubMed ID: 5017549
    [No Abstract]   [Full Text] [Related]  

  • 22. L-dopa therapy in Parkinson's disease.
    Murray TJ
    N S Med Bull; 1972 Jun; 51(3):67-70. PubMed ID: 4504954
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of Parkinson's disease with L-dopa therapy.
    Tyler E
    Can Nurse; 1971 Apr; 67(4):41-2. PubMed ID: 5549360
    [No Abstract]   [Full Text] [Related]  

  • 24. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L; Martin JD; Gutrecht JA
    W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660
    [No Abstract]   [Full Text] [Related]  

  • 25. L-Dopa therapy in Parkinson's disease (a year's experience with 20 patients).
    Fincham RW; Decker DA
    J Iowa Med Soc; 1970 Nov; 60(11):755-9. PubMed ID: 5482403
    [No Abstract]   [Full Text] [Related]  

  • 26. [The treatment of Parkinson's disease with L-dopa].
    Dalle Ore G; Bricolo A; Robotti E; Bazzan A; Mazza C
    Policlinico Prat; 1970 Apr; 77(16):509-24. PubMed ID: 5443873
    [No Abstract]   [Full Text] [Related]  

  • 27. [Levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G; Cannella M
    Minerva Med; 1969 Nov; 60(95):4733-45. PubMed ID: 5357313
    [No Abstract]   [Full Text] [Related]  

  • 28. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
    Herskovits E; Matera R; Gacitua EF
    Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy of Parkinson's syndrome with L-dopa only and in combination with a decarboxylase inhibitor. A comparison].
    Feise G; Paal G
    Nervenarzt; 1974 Mar; 45(3):126-32. PubMed ID: 4832035
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychiatric disturbances in Parkinson's disease.
    Celesia GG; Wanamaker WM
    Dis Nerv Syst; 1972 Sep; 33(9):577-83. PubMed ID: 4649149
    [No Abstract]   [Full Text] [Related]  

  • 31. Mortality in patients with Parkinson's disease treated with dopa.
    Singer RB
    J Insur Med; 1992; 24(2):126-7. PubMed ID: 10148480
    [No Abstract]   [Full Text] [Related]  

  • 32. [L-dopa in the treatment of Parkinson's disease. Preliminary report].
    Poch GF
    Prensa Med Argent; 1969 Oct; 56(34):1629-32. PubMed ID: 5405572
    [No Abstract]   [Full Text] [Related]  

  • 33. L-dopa induced dyskinesias in 152 patients with Parkinson's disease.
    Mones RJ; Elizan TS; Siegel G
    Trans Am Neurol Assoc; 1970; 95():286-7. PubMed ID: 5514393
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of Parkinson's syndrome with L-dopa].
    Ljung O
    Lakartidningen; 1972 Jun; 69(24):2940-4. PubMed ID: 5037135
    [No Abstract]   [Full Text] [Related]  

  • 35. [Parkinson's disese. Treatment with L-dopa].
    Herskovits E; Matera R
    Prensa Med Argent; 1969 Oct; 56(35):1674-80. PubMed ID: 5399419
    [No Abstract]   [Full Text] [Related]  

  • 36. [L-Dopa in the treatment of Parkinson's disease].
    Warot P
    Lille Med; 1971; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract]   [Full Text] [Related]  

  • 37. The modifying influence of L-dopa on the physical therapy program in Parkinson's disease.
    Blonsky ER; Minnigh EC
    Prog Phys Ther; 1970; 1(1):55-74. PubMed ID: 5523796
    [No Abstract]   [Full Text] [Related]  

  • 38. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA; De la Herrán J
    Rev Clin Esp; 1970 Dec; 119(6):555-62. PubMed ID: 5509794
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with L-DOPA (Eldopal) treatment of 40 patients with Parkinson's disease].
    Postma JU; Stam FC; Meerlo HJ
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):701-7. PubMed ID: 5551426
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Neurology; 1970 Apr; 20(4):376-7. PubMed ID: 4935022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.